Myofascial Trigger Point PainNCT05873010
Manual Compression and Stretching for The Myofascial Trigger Points in Upper Trapezius and Levator Scapulae
A study testing Manual Compression and Stretching in people with Myofascial Trigger Point Pain, run by Superior University at 1 site in Pakistan.
Trial summary
To compare the effectiveness of manual compression and stretching for myofascial trigger points in upper trapezius and levator scapulae in male office workers Read more about this study
- Who is it for?
- Ages 25 to 45 years, men only
- Conditions the study is for
- Myofascial Trigger Point Pain
- What is being tested?
- Manual Compression and Stretching
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 sitePakistan
- Study dates
- 1 Apr 2023to 31 Aug 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 45 years
- Men only
- No healthy volunteers
- Adult
Who may be able to join
- male office workers with age of 25-45 working from Monday to Friday for 6-8 hours in a day.
Who cannot join
- male office workers having any past trauma, chronic illness, any recent surgery and systemic diseases.
Trial locations and contacts
1 site in 1 country.
Pakistan1 site, 1 recruiting
- Recruiting
Chaudary Muhammad Akram Teaching Hospital
Lahore, Punjab Province
About this study
Official title: Effectiveness Of Manual Compression and Stretching for The Myofascial Trigger Points in Upper Trapezius and Levator Scapulae
To compare the effectiveness of manual compression and stretching for myofascial trigger points in upper trapezius and levator scapulae in male office workers
- Conditions
- Myofascial Trigger Point Pain
- Being tested
- Manual Compression and Stretching
- Medical subject headings
- Myofascial Pain Syndromes
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Manual Compression and StretchingDiagnostic test
Manual Compression and Stretching for The Myofascial Trigger Points
| Study group | Role | What they receive |
|---|---|---|
| Manual Compression and Stretching | Experimental | Not described Receives: Diagnostic Test: Manual Compression and Stretching |
What is being measured
The primary outcome is the main question the study is designed to answer.
VAS (visual analogue scale) for pain
Stretching for The Myofascial Trigger Points in Upper Trapezius and Levator Scapulae using VAS
Measured: 6 Months
mechanical algometer Scale for pain
Stretching for The Myofascial Trigger Points in Upper Trapezius and Levator Scapulae using mechanical algometer
Measured: 6 Months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 May 2023
- Study start1 Apr 2023
- Primary completion1 Jun 2023 (estimated)
- Study completion31 Aug 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Myofascial Trigger Point PainStudies of the same condition, open and under way.
- More trials run by Superior UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Superior University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Muhammad Naveed Babur, Superior University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05873010
- Sponsor's protocol ID
- DPT/Batch-Fall18/546
- Status last verified
- May 2023
- First submitted
- 18 Mar 2023
- Last updated
- 24 May 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 May 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness Of Manual Compression and Stretching for The Myofascial Trigger Points in Upper Trapezius and Levator Scapulae
- ClinicalTrials.gov ID
- NCT05873010
- Acronym / sponsor ID
- DPT/Batch-Fall18/546
- Conditions
- Myofascial Trigger Point Pain
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Superior UniversityUniversity, hospital or other
- Study start
- 1 Apr 2023 (actual)
- Primary completion
- 1 Jun 2023 (estimated)
- Study completion
- 31 Aug 2023 (estimated)
- First posted
- 24 May 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To compare the effectiveness of manual compression and stretching for myofascial trigger points in upper trapezius and levator scapulae in male office workers
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Manual Compression and Stretching | Experimental | Diagnostic Test: Manual Compression and Stretching |
Who may qualify
- Ages
- 25 to 45 years
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- male office workers with age of 25-45 working from Monday to Friday for 6-8 hours in a day.
Key exclusion criteria (1 listed)
- male office workers having any past trauma, chronic illness, any recent surgery and systemic diseases.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Manual Compression and StretchingManual Compression and Stretching for The Myofascial Trigger Points | Diagnostic test | Manual Compression and Stretching |
Primary outcome
VAS (visual analogue scale) for pain
Time frame: 6 Months
Stretching for The Myofascial Trigger Points in Upper Trapezius and Levator Scapulae using VAS
mechanical algometer Scale for pain
Time frame: 6 Months
Stretching for The Myofascial Trigger Points in Upper Trapezius and Levator Scapulae using mechanical algometer
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 May 2023.
- Individual participant dataSharing planned: No
Related trials for Myofascial Trigger Point Pain
Recruiting
Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain Syndrome
Myofacial Pain, Myofacial Pain Syndrome
Not yet recruiting
Focused Versus Multi-Target Trigger Point Injection for Chronic Myofascial Neck Pain
Myofacial Pain Syndrome, Chronic Neck Pain
Recruiting
Comparing Myofascial Exercise and Trigger Point Therapy for Non-Specific Low Back Pain
Non-specific Low Back Pain
Not yet recruitingPhase 4
Botulinum Toxin Type A Versus Triamcinolone for Facial Myalgia
Myofascial Pain Syndrome (MPS)
Not yet recruiting
Comparison of Suboccipital Release and Muscle Energy Technique in Subjects With Mechanical Neck Pain and Forward Head Posture
Myofascial Trigger Points, Neck Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Manual Compression and Stretching in people with Myofascial Trigger Point Pain, run by Superior University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 24 May 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Nimra Zaheer, DPT (+923235018078, nimrazaheer62@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
VAS (visual analogue scale) for pain (time frame: 6 Months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 May 2023.